Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Other Operating Expenses (2016 - 2024)

Perspective Therapeutics (CATX) has disclosed Other Operating Expenses for 15 consecutive years, with $32000.0 as the latest value for Q4 2024.

  • Quarterly Other Operating Expenses rose 45.45% to $32000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $32000.0 through Sep 2025, up 45.45% year-over-year, with the annual reading at -$27000.0 for FY2024, N/A changed from the prior year.
  • Other Operating Expenses hit $32000.0 in Q4 2024 for Perspective Therapeutics, up from $22000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.6 million in Q1 2022 to a low of -$13.0 million in Q4 2022.
  • Historically, Other Operating Expenses has averaged -$1.5 million across 5 years, with a median of $22000.0 in 2023.
  • Biggest five-year swings in Other Operating Expenses: surged 80400.0% in 2020 and later crashed 1134.3% in 2022.
  • Year by year, Other Operating Expenses stood at -$7000.0 in 2020, then surged by 10971.43% to $761000.0 in 2021, then plummeted by 1806.44% to -$13.0 million in 2022, then skyrocketed by 100.17% to $22000.0 in 2023, then skyrocketed by 45.45% to $32000.0 in 2024.
  • Business Quant data shows Other Operating Expenses for CATX at $32000.0 in Q4 2024, $22000.0 in Q4 2023, and -$22000.0 in Q1 2023.